Figure 3From: Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcomaFrequency of CTLs analyzed by HLA-A24/peptide tetramers in the case 4 patient. Frequencies of each analysis were described in Table 2.Back to article page